In 1958, this man’s heart kept stopping—20 times a day.
Doctors had no solution.
Then his wife demanded an experimental surgery that had only been tested on dogs.
What happened next changed medicine forever. 🧵
Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. Full EARLY TAVR trial results: https://t.co/bmCLd0EtUf #TCT2024
🔥 finally out in @ehj_ed: therapy duration and improvement of ventricular function in de-novo heart failure (HF-OPT)
Worth waiting! ⏳
https://t.co/vJbyUAxHPd
@DrV_Mann@JBauersachsMD
Has the time come for routine use of quantitative #LGE by #whyCMR for sudden cardiac death risk stratification in hypertrophic #cardiomyopathy? 🤔 https://t.co/smb7dLjUoA
#cvHCM#JACCIMG
In an elderly population w/ #vhdAS, one-half of pts had changes in cardiac stage early after #TAVR. The extent of extra-aortic valve cardiac damage before & after TAVR & changes in cardiac stage early after TAVR have important prognostic implications during long-term follow-up. https://t.co/FYgECMZWZh #JACCINT
Freue mich sehr auf meine neue Aufgabe! Interdisziplinarität und gute Lehre werden zum Erfolg der GSM+ für Patient:innen und Studierende beitragen. Hallo @unimedmagdeburg Danke an die @ChariteBerlin ! @DGK_org@dzhk_germany
Hot of press 🔥🔥 Herzinsuffizienz: Leitlinien-Update der ESC 2023 | SpringerLink von @JBauersachsMD und mir. Was ist neu ? Was ist wichtig ? 🚨schaut mal rein ! @DavidDuncker @HenrikeHillmann @MHH_life @YoungDgk https://t.co/k6EffMUyro